Common Contracts

EX-10.32 14 dex1032.htm AMENDMENT TO LICENSE AGREEMENT NOTE: Portions of this Exhibit are the subject of a Confidential Treatment Request by the Registrant to the Securities and Exchange Commission (the “Commission”). Such portions have been redacted...

License Agreement • May 5th, 2020

• Contract Type
  License Agreement
• Filed
  May 5th, 2020

THIS AMENDMENT TO LICENSE AGREEMENT (the “Amendment”) is made and entered into effective as of April 29, 2008 (the “Amendment Effective Date”), by and between The Scripps Research Institute, a California nonprofit public benefit corporation (“Scripps”), and Sangamo BioSciences, Inc., a Delaware corporation (“Licensee”), having principal offices at 501 Canal Blvd., Suite A100, Richmond, CA 94804.

AMENDMENT TO LICENSE AGREEMENT

License Agreement • March 5th, 2010 • Sangamo Biosciences Inc • Biological products, (no disgnostic substances)

• Contract Type
  License Agreement
• Filed
  March 5th, 2010
• Company
  Sangamo Biosciences Inc
• Industry
  Biological products, (no disgnostic substances)

THIS AMENDMENT TO LICENSE AGREEMENT (the “Amendment”) is made and entered into effective as of April 29, 2008 (the “Amendment Effective Date”), by and between The Scripps Research Institute, a California nonprofit public benefit corporation (“Scripps”), and Sangamo BioSciences, Inc., a Delaware corporation (“Licensee”), having principal offices at 501 Canal Blvd., Suite A100, Richmond, CA 94804.